Towards personalised medicine in lung and thymus neuroendocrine tumours. (2017)
Attributed to:
MICA: Immunotherapy for oral cancer prevention and treatment
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1470-2045(17)30784-2
PubMed Identifier: 29074101
Publication URI: http://europepmc.org/abstract/MED/29074101
Type: Journal Article/Review
Volume: 18
Parent Publication: The Lancet. Oncology
Issue: 12
ISSN: 1470-2045